HER2/neu Testing In 432 Consecutive Breast Cancer Cases using FISH and IHC - A Comparative Study

INTRODUCTION: The development of trastuzumab, a HER-2/neu targeted monoclonal antibody resulted in significant improvements in clinical response and survival in HER-2/neu gene amplified group of patients. Thus, accurate assessment of HER-2/neu status becomes critical. Fluorescence In Situ Hybridizat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Diagn Res
Main Authors: Eswarachary, Venkataswamy, Mohammed, Imran Gorur, Jayanna, Prashanth K, Patilokaly, Geeta V, Nargund, Ashwini R, Dhondalay, Gopal Krishna, Prabhudesai, Shilpa, Sahoo, Rashmita
Formato: Artigo
Idioma:Inglês
Publicado em: JCDR Research and Publications (P) Limited 2017
Assuntos:
Pathology Section
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5449786/
https://ncbi.nlm.nih.gov/pubmed/28571140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/25625.9521
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados